Virion Therapeutics Reports New Data from Two Clinical Presentations at EASL 2025, including Rapid and Profound ...
PHILADELPHIA, PA, UNITED STATES, May 7, 2025 /EINPresswire.com/ -- - Highlights from the Data Presentations • Over 8,295 and 821 safety days reported in VRON-0200 alone (n=27), and VRON-0200 combination treated patients (n=7), respectively; …